Archives
-
CCG-1423 RhoA Inhibitor: Workflow Guide
2026-08-28
CCG-1423 is a pathway-focused RhoA inhibitor for separating MRTF-A nuclear signaling from broader cytoskeletal responses. This guide translates its mechanism into practical cancer research, apoptosis, invasion, barrier, and exploratory viral-entry workflows while emphasizing controls and interpretation limits.
-
Protein A/G Magnetic Co-IP/IP Kit for BATF2 Studies
2026-08-28
A practical workflow for testing BATF2–ATF3 relationships, ubiquitin-linked stability, and protein-complex composition in intervertebral disc degeneration models. The Protein A/G Magnetic Co-IP/IP Kit combines Fc-selective capture, rapid magnetic handling, and SDS-PAGE- or mass spectrometry-ready elution for reproducible interaction studies.
-
Dicoumarol Targets IRE1α in ER Stress Liver Injury
2026-08-27
Yang and colleagues developed a screening workflow that combines kinase-domain molecular docking with an XBP1s reporter assay to identify dicoumarol as an inhibitor of IRE1α activation. The compound reduced tunicamycin- and carbon tetrachloride-associated endoplasmic reticulum stress and protected mice from acute liver injury, providing a mechanistically focused route for compound discovery.
-
Estradiol–Autophagy Axis in Perimenopausal Aging
2026-08-27
This study integrates NHANES analysis, network pharmacology, and perimenopausal mouse experiments to examine how declining estradiol relates to multi-organ disease risk. Its central contribution is mechanistic evidence that estrogen receptor activity and downstream autophagy jointly protect the heart, aorta, and kidneys from fibrosis during perimenopausal aging.
-
Norepinephrine Bitartrate: A Dose-Aware Research Guide
2026-08-26
Norepinephrine bitartrate connects adrenergic receptor biology with dose-aware cardiovascular research. This guide interprets clinical vasopressor conversion data for assay design without confusing clinical dose ratios with in vitro concentration equivalence.
-
15-PGDH Inhibition During Semaglutide Weight Loss
2026-08-26
The reference study identifies 15-PGDH inhibition as a complementary strategy for maintaining muscle quality during semaglutide-associated weight loss. In obese mice, combining a 15-PGDH inhibitor with semaglutide improved muscle stem cell activity, regenerated myofiber growth, and force recovery without reducing the drug’s weight-loss effect.
-
Mast Cell–Mesothelial Crosstalk in Peritoneal Fibrosis
2026-08-25
Chen et al. identify tryptase/PAR2 signaling as a mechanistic link between mast-cell activation and peritoneal mesothelial fibrosis during exposure to high-glucose peritoneal dialysis fluid. Using chemical profiling, multi-omics, cell models, and a mouse model, the study shows that Astragalus membranaceus and Salvia miltiorrhiza suppress mast-cell degranulation and downstream MAPK/NF-κB signaling, providing a framework for investigating inflammatory crosstalk in peritoneal fibrosis.
-
HRP Goat Anti-Mouse IgG: Assay Design for CRC
2026-08-25
Discover how Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP Conjugated supports orthogonal validation of AQP9 biology in KRASG12V colorectal cancer. This guide connects secondary-antibody chemistry with assay controls, tissue interpretation, and reproducible Western blot, ELISA, IHC, and ICC workflows.
-
Puromycin and Precision Gene Therapy Workflows
2026-08-24
Puromycin dihydrochloride is more than a routine selection reagent. Its defined ribosomal mechanism can sharpen cell-engineering workflows, while recent AAV capsid research shows how disciplined functional validation can support more precise gene-delivery strategies.
-
H-89 in Wnt–PKA Osteoblast Assays
2026-08-24
H-89 is a cAMP-dependent protein kinase inhibitor that helps resolve how Wnt-triggered PKA activity influences O-GlcNAcylation, glycolysis, and osteoblast formation. This article presents an assay-centered framework for separating pathway timing, metabolic effects, and inhibitor-specific limitations.
-
1-methyl Adenosine: Assay Workflows & Applications
2026-08-23
1-methyl Adenosine, also called 1-methyl Ado or m1A, connects modified-nucleoside biology with targeted cellular metabolomics. This guide translates stable isotope-diluted UHPLC–MS/MS findings into practical workflows for RNA modification research, cancer metabolism studies, biomarker discovery, and therapeutic target validation.
-
Chemerin–cNTS Signaling Raises Sympathetic Activity
2026-08-22
A 2024 European Journal of Neuroscience study identifies a chemerin–CMKLR1–NADPH oxidase–superoxide pathway in the caudal nucleus tractus solitarius (cNTS) that increases renal sympathetic activity, blood pressure, and heart rate. Its pharmacological dissection further indicates that the downstream paraventricular nucleus relay is NMDA-sensitive rather than dependent on AMPA/kainate receptors.
-
Bardoxolone Methyl: Redox-State Assay Logic
2026-08-22
Bardoxolone methyl, also called CDDO methyl ester, is examined here through a redox-state and replication-stress lens. Learn how to distinguish Nrf2 pathway engagement, NF-kB inhibition, thioredoxin remodeling, and nonspecific cytotoxicity in translational assays.
-
Pemetrexed Workflows for Mesothelioma Research
2026-08-21
Build mechanism-guided Pemetrexed assays that connect antifolate stress with proliferation, apoptosis, senescence, and DNA-repair vulnerability. The workflow is designed for cancer chemotherapy research, with practical decision points for non-small cell lung carcinoma research and malignant mesothelioma models.
-
Dasatinib Monohydrate: BMS-354825 Research Guide
2026-08-20
Dasatinib Monohydrate, also known as BMS-354825, is an ATP-competitive multitargeted tyrosine kinase inhibitor with strong ABL and SRC activity. Its best-established research value is imatinib-resistant BCR-ABL inhibition in chronic myeloid leukemia and Philadelphia chromosome positive leukemia, while patient-derived assembloids provide a controlled platform for testing stromal effects on drug response.